JOHNSON & JOHNSON logo

JOHNSON & JOHNSON

JNJ
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 28, 2026
Order
RatiosJun 28, 2026Mar 29, 2026Sep 28, 2025Jun 29, 2025Mar 30, 2025Sep 29, 2024Jun 30, 2024Mar 31, 2024Oct 1, 2023Jul 2, 2023Apr 2, 2023Oct 2, 2022Jul 3, 2022Apr 3, 2022Oct 3, 2021Jul 4, 2021Apr 4, 2021Sep 27, 2020Jun 28, 2020Mar 29, 2020Sep 29, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jul 1, 2018Apr 1, 2018Oct 1, 2017Jul 2, 2017Apr 2, 2017Oct 2, 2016Jul 3, 2016Apr 3, 2016Sep 27, 2015Jun 28, 2015Mar 29, 2015Sep 28, 2014Jun 29, 2014Mar 30, 2014Sep 29, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jul 1, 2012Apr 1, 2012Oct 2, 2011Jul 3, 2011Apr 3, 2011Oct 3, 2010Jul 4, 2010Apr 4, 2010Sep 27, 2009Jun 28, 2009
Gross Margin
68.19%
66.31%
69.56%
67.87%
66.40%
69.01%
69.40%
69.55%
69.06%
67.83%
66.08%
67.19%
Operating Margin
28.34%
26.58%
29.58%
28.26%
28.31%
22.60%
28.77%
28.40%
27.62%
26.73%
26.68%
26.47%
Pretax Margin
26.66%
24.89%
31.23%
27.34%
62.26%
14.85%
25.61%
17.37%
24.43%
26.49%
-2.98%
24.47%
Effective Tax Rate
17.98%
12.60%
31.24%
14.70%
19.31%
19.29%
18.48%
12.36%
17.40%
23.93%
90.77%
23.43%
Net Margin
21.86%
21.76%
21.47%
23.32%
50.24%
11.99%
20.88%
15.22%
121.91%
20.15%
-0.27%
18.74%
Current Ratio
1.09x
1.03x
1.07x
1.01x
1.26x
1.03x
1.07x
1.17x
1.21x
1.12x
1.07x
1.43x
Debt to Equity
1.37x
1.47x
1.43x
1.46x
1.48x
1.54x
1.53x
1.46x
1.33x
1.51x
1.77x
1.35x
Net Debt to Equity
1.13x
1.21x
1.20x
1.23x
0.99x
1.26x
1.18x
1.09x
1.05x
1.23x
1.49x
1.20x
Asset Turnover
12.59%
11.98%
12.44%
12.28%
11.30%
12.60%
12.40%
12.43%
12.86%
13.32%
12.63%
13.59%
Return on Equity
6.51%
6.45%
6.50%
7.06%
14.08%
3.84%
6.55%
4.65%
36.54%
6.73%
-0.10%
5.98%
Return on Assets
2.75%
2.61%
2.67%
2.86%
5.68%
1.51%
2.59%
1.89%
15.67%
2.68%
-0.03%
2.55%